EVAXION BIOTECH A S's ticker is EVAX and the CUSIP is 29970R105. A total of 11 filers reported holding EVAXION BIOTECH A S in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Moloney Securities Asset Management, LLC | 11,000 | $9,163 | 0.00% |
| Beacon Capital Management, LLC | 6,881 | $9,014 | 0.00% |
| RHUMBLINE ADVISERS | 2,109 | $1,813 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 11,000 | $9,460 | 0.00% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 32,774 | $28,186 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 15,188 | $12,652 | 0.00% |
| JPMORGAN CHASE & CO | 9,283 | $7,983 | 0.00% |
| MORGAN STANLEY | 3,446 | $2,871 | 0.00% |
| GROUP ONE TRADING, L.P. | 386 | $332 | 0.00% |
| AE Wealth Management LLC | 48,633 | $40,511 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| UBS Group AG | 4,005 | $3,336 | 0.00% |
External links
This page lists EVAXION BIOTECH A S's shareholders in Q3 2023. To view EVAXION BIOTECH A S's shareholder history, click here.